CytoReason Expands Its Reach in Asia, Forging Commercial Alliance with Helixrus to Leverage Machine Learning in Drug Development for Korean Drugmakers
TEL AVIV, Israel and SEOUL, South Korea, April 12, 2022 /PRNewswire/ -- CytoReason, a leading developer of computational disease models for...